ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Northwest Biotherapeutics Capital Limited

Northwest Biotherapeutics Capital Limited is an active company incorporated on 26 June 2014 with the registered office located in London, City of London. Northwest Biotherapeutics Capital Limited was registered 11 years ago.
Status
Active
Active since incorporation
Company No
09103328
Private limited company
Age
11 years
Incorporated 26 June 2014
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 26 June 2025 (6 months ago)
Next confirmation dated 26 June 2026
Due by 10 July 2026 (6 months remaining)
Last change occurred 2 years 6 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (9 months remaining)
Contact
Address
The St Botolph Building, 138
Houndsditch
London
EC3A 7AR
United Kingdom
Address changed on 22 Jan 2024 (1 year 11 months ago)
Previous address was Suite 1, 3rd Floor 11-12 st. James's Square London SW1Y 4LB United Kingdom
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
1
Shareholders
1
Controllers (PSC)
1
Director • American • Lives in United States • Born in Oct 1955
Northwest Biotherapeutics Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Advent Bioservices Ltd
Linda Fairing Powers is a mutual person.
Active
Northwest Biotherapeutics Limited
Linda Fairing Powers is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£41K
Increased by £12K (+41%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£19.29M
Increased by £338K (+2%)
Total Liabilities
-£20.92M
Increased by £367K (+2%)
Net Assets
-£1.63M
Decreased by £29K (+2%)
Debt Ratio (%)
108%
Increased by 0% (0%)
Latest Activity
Full Accounts Submitted
2 Months Ago on 30 Sep 2025
Northwest Biotherapeutics Limited (PSC) Details Changed
3 Months Ago on 1 Sep 2025
Confirmation Submitted
5 Months Ago on 10 Jul 2025
Full Accounts Submitted
1 Year 2 Months Ago on 30 Sep 2024
Confirmation Submitted
1 Year 6 Months Ago on 26 Jun 2024
Aracaris Limited (PSC) Details Changed
1 Year 11 Months Ago on 22 Jan 2024
Registered Address Changed
1 Year 11 Months Ago on 22 Jan 2024
Vistra Cosec Limited Resigned
2 Years Ago on 11 Dec 2023
Full Accounts Submitted
2 Years 3 Months Ago on 30 Sep 2023
Confirmation Submitted
2 Years 6 Months Ago on 28 Jun 2023
Get Credit Report
Discover Northwest Biotherapeutics Capital Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 31 December 2024
Submitted on 30 Sep 2025
Change of details for Northwest Biotherapeutics Limited as a person with significant control on 1 September 2025
Submitted on 1 Sep 2025
Confirmation statement made on 26 June 2025 with no updates
Submitted on 10 Jul 2025
Total exemption full accounts made up to 31 December 2023
Submitted on 30 Sep 2024
Confirmation statement made on 26 June 2024 with no updates
Submitted on 26 Jun 2024
Registered office address changed from Suite 1, 3rd Floor 11-12 st. James's Square London SW1Y 4LB United Kingdom to The St Botolph Building, 138 Houndsditch London EC3A 7AR on 22 January 2024
Submitted on 22 Jan 2024
Change of details for Aracaris Limited as a person with significant control on 22 January 2024
Submitted on 22 Jan 2024
Certificate of change of name
Submitted on 22 Jan 2024
Termination of appointment of Vistra Cosec Limited as a secretary on 11 December 2023
Submitted on 19 Dec 2023
Total exemption full accounts made up to 31 December 2022
Submitted on 30 Sep 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year